“Cannabis may be mankind's first cultivated plant, but it has never lost its wildness.”Dale Pendell, Pharmako/Poeia
STATION 01The still point
One mother molecule, a whole family
Everything the plant makes begins as one compound, cannabigerolic acid. Its enzymes branch it into the acid forms; heat and time turn those into the cannabinoids people know. The thread you have been following unravels here into that genealogy. It is the same shape at every scale: one becoming many.
Cannabis cannabinoid biosynthesis constellation.
Read the same data as a table
| Molecule | Name | Formula | Character |
|---|
Sources, station 01
- Bow EW, Rimoldi JM. Structure-function of classical cannabinoids. Perspect Med Chem. 2016. PMID 27398024
- Pertwee RG. Diverse CB1/CB2 pharmacology of three plant cannabinoids. Br J Pharmacol. 2008. PMID 17828291
- Cascio MG, et al. Cannabigerol at alpha2-adrenoceptor / 5-HT1A. Br J Pharmacol. 2010. PMID 20002104
- Bolognini D, et al. Cannabidiolic acid, 5-HT1A, anti-nausea. Br J Pharmacol. 2013. PMID 23121618
- Perrotin-Brunel H, et al. Decarboxylation of THC: kinetics (activation energy ~85 kJ/mol). J Mol Struct. 2011. DOI 10.1016/j.molstruc.2010.11.061
STATION 02The aromatics
The scent is chemistry too
Terpenes are the plant's volatile oils: the pine, the citrus, the pepper you smell. They are the language cannabis shares with the wider botanical world, which is why a note of it lives in hops, in lavender, in black pepper. The effects folklore hangs on them are mostly animal-model and inhalation studies, suggestive rather than settled.
Sources, station 02
- Rao VS, et al. Myrcene and nociception in mice. J Pharm Pharmacol. 1990. PMID 1983154; da-Silva VA, et al. (negative anxiolytic finding) Braz J Med Biol Res. 1991. PMID 1797273
- Lima NGPB, et al. Anxiolytic-like (+)-limonene. Pharmacol Biochem Behav. 2013. PMID 22995322
- Lee GY, et al. alpha-Pinene, memory. 2017. PMID 29234406; Yang H, et al. alpha-Pinene, GABAA sleep. 2016. PMID 27573669
- Linck VM, et al. Inhaled linalool sedation. Phytomedicine. 2009. PMID 18824339; Cline M, et al. AANA J. 2008. PMID 18323320
- Gertsch J, et al. beta-caryophyllene "dietary cannabinoid". PNAS. 2008. PMID 18574142 (CB2 claim); Finlay DB, et al. Front Pharmacol. 2020. PMID 32269529 and Santiago M, et al. 2019. PMID 31559333 (both failed to reproduce it)
“She's cosmopolitan: internationalism is one of her special skills. She knows how to ‘get around,’ and needs to — especially this last half century, with every border so determined to keep her out.”Dale Pendell, Pharmako/Poeia
STATION 03How it meets the human body
A system that was already there
Lock and key: the body's own cannabinoids and the plant's.
The body makes anandamide and 2-AG, lipids shaped to fit the CB1 receptor that is dense in the nervous system. THC, from the plant, walks into the same binding pocket as a partial agonist. The plant did not invent a lock; it happened to fit one the body was already using. A terpene, beta-caryophyllene, was once thought to fit the CB2 receptor directly, but two independent studies since have failed to reproduce that, so it is drawn here as a disputed link.
THC works by walking directly into the pocket on CB1 that the body's own signals use. It binds as a partial agonist: per receptor it does not push as hard as a full agonist could, but it binds tightly, lingers far longer than a natural endocannabinoid, and reaches nearly every CB1 at once rather than the handful at one working synapse. The effect is large and diffuse rather than local and self-correcting. That is the high.
CBD's story is genuinely different, and worth resisting the tidy shorthand about calming what THC excites. CBD has only weak direct affinity for CB1; its best-documented action there is as a negative allosteric modulator, and its clearest clinical win, controlling seizures in severe childhood epilepsy, appears not to run through cannabinoid receptors at all. It looks like the sum of many soft, indirect actions rather than one dominant lever.
Sources, station 03
- Gaoni Y, Mechoulam R. Isolation/structure of THC. J Am Chem Soc. 1964;86:1646
- Matsuda LA, et al. CB1 cloned. Nature. 1990. PMID 2165569; Munro S, et al. CB2 cloned. Nature. 1993. PMID 7689702
- Devane WA, et al. Anandamide. Science. 1992. PMID 1470919; Mechoulam R, et al. 2-AG. Biochem Pharmacol. 1995. PMID 7605349
- Laprairie RB, et al. CBD is a CB1 negative allosteric modulator. Br J Pharmacol. 2015. PMID 26218440
STATION 04Botany and taxonomy
What the plant is
Carl Linnaeus opened the modern record in 1753, calling the genus a single species, Cannabis sativa, whose epithet just means "cultivated." In 1785 Lamarck, examining Indian specimens, argued for a second, Cannabis indica: shorter, denser, chemically different. A third name later followed for the wild Central Asian type, ruderalis. That split still organizes both the science and the marketplace lore, even though the two conversations have drifted apart.
Whether the three deserve full species status is genuinely unsettled. In 1976 Small and Cronquist folded the genus into one variable species; Schultes and colleagues argued for three. Molecular work has not closed it: a 2015 SNP study found a clean drug/fiber split, a 2020 study found five clusters. It is a live disagreement, not a settled question with one wrong side.
On sight the plant is unmistakable: annual, usually either male or female, with palmate leaves of seven or nine serrated leaflets. Botanists even read its venation like a fingerprint. It is on the female flowers, along the calyxes and bracts, that the glandular trichomes crowd most densely, the microscopic resin factories that make everything at the still point above. Chemists sort plants not by leaf shape but by chemotype, the genetically fixed ratio of THC to CBD; that axis, not height or leaf width, is the one that holds up in the lab, and it is the one written into law (hemp is defined as under 0.3% THC).
The deep story runs deeper than people. Molecular clocks trace the genus to the northeastern Tibetan Plateau roughly 27.8 million years ago. A 2021 whole-genome study of 110 accessions places the plant's domestication around twelve thousand years ago in early Neolithic East Asia, and dates the fiber-type / drug-type split to roughly four thousand years ago, several millennia later.
Sources, station 04
- Ren G, et al. Domestication history of Cannabis sativa (whole-genome resequencing). Sci Adv. 2021. PMID 34272249
- Small E, Cronquist A. A practical and natural taxonomy for Cannabis. Taxon. 1976 (single-species scheme; 0.3% THC threshold origin)
- Botany, taxonomy, sex determination, chemotype: Wikipedia (Tier 4, tertiary), verified per claim in the content package
STATION 05Ethnobotany and history
The people who kept it
The richest part of the story is not the molecule. It is the twelve thousand years of hands.
Long before agriculture had a name, on the steppes and foothills from the Caucasus to the Altai, a wind-pollinated weed struck up a partnership with human beings that would outlast every empire built afterward. It colonized the disturbed, nitrogen-rich ground that gathers wherever people camp and till. Hemp fiber left its imprint on Yangshao pottery in China by the fifth millennium BC.
China keeps the fiber side in its writing: the character for hemp shows two plants drying under a shelter, and the same character doubles as the word for "numb," the plant's other nature hiding inside the script. Its psychoactive use enters the written medical record in the Shennong Bencaojing, and Taoist practice added it to ritual incense by the sixth century.
Westward, Herodotus around 440 BC described the Scythians creeping under felt tents, throwing hemp seed on hot stones, and inhaling the smoke, shouting for joy. Twentieth-century archaeology vindicated him almost exactly: the frozen Pazyryk kurgans of the Altai gave up bronze censers still holding charred hemp seed beside collapsible tent frames, from the fifth to second centuries BC.
India built the longest religious relationship of any culture, with a vocabulary precise by potency: bhang from the leaves, ganja from the flowering tops, charas the hand-rubbed resin. Shiva carries the epithet Lord of Bhang; during Holi and Maha Shivratri devotees still drink bhang as a sacrament, and wandering sadhus have long used it as an aid to renunciation. From Persia the drug-type lineage moved into the Islamic world as hashish, carried by Sufi orders pursuing altered states as a path to the divine.
The plant crossed the Atlantic with colonization, first as fiber: English settlers found hemp already growing in Powhatan Virginia, and by 1619 the House of Burgesses compelled every planter to sow it. It reentered Western medicine in the 1840s through William O'Shaughnessy, who brought preparations back from Calcutta, and through the Paris Club des Hashischins. That medical normalization gave way within a lifetime to prohibition, from the 1937 US Marihuana Tax Act to the 1961 UN Single Convention, and then, slowly, swung back: the Netherlands from 1976, California's 1996 medical law, Uruguay's full legalization in 2013, Canada in 2018.
Sources, station 05
- Ren G, et al. Sci Adv. 2021. PMID 34272249 (origin and domestication dating)
- Herodotus, Histories 4.75; Pazyryk kurgan finds (Rudenko excavations)
- Crocq MA. History of cannabis. Dialogues Clin Neurosci. 2020. PMID 33162765
- Ethnobotany, religion, prohibition arc: Wikipedia (Tier 4), verified per claim; legalization dates independently confirmed
“The true living Dionysus is hiding in the hemp plant, not in the wine bottle.”Dale Pendell, Pharmako/Poeia
STATION 06What the evidence shows
Honest about the medicine
A homage should not overclaim. The evidence is strong in a few narrow places, real but modest in others, and thin almost everywhere the marketing is loudest. Here it is graded plainly.
| Indication | Evidence | What it rests on |
|---|---|---|
| Seizures in Dravet and Lennox-Gastaut syndromes (purified CBD) | strong | Randomized placebo-controlled trials; basis of the approved drug Epidiolex |
| Chemotherapy nausea and vomiting (nabilone, dronabinol) | strong | RCTs; now a second-line adjunct behind newer antiemetics |
| Multiple-sclerosis spasticity (nabiximols / Sativex) | moderate | Approved add-on in the UK and EU for refractory spasticity |
| Appetite loss in HIV/AIDS wasting (dronabinol) | moderate | Placebo-controlled trial: appetite and weight vs placebo |
| Chronic pain | weak to modest | Meta-analyses find a small-to-very-small effect, not a strong one |
| Anxiety, PTSD, sleep, IBD, glaucoma | insufficient | Low-quality or inadequate evidence for clinical recommendation |
Safety, plainly. Cannabis intoxication essentially never kills by respiratory depression the way opioids do, because CB1 is sparse in the brainstem breathing centers. It is not without harm: heavy long-term use carries a recognized cyclic-vomiting syndrome, a real cannabis use disorder (around 1.4 to 1.5% of US adults in survey years), and a dose-related association with psychosis that is well documented but whose causal share is still debated. A 2025 signal on cardiovascular risk exists but has drawn published methodological criticism, so it belongs in the "real but disputed" column. Use in pregnancy carries documented risk and should be avoided.
Interactions worth naming. CBD raises levels of the antiseizure drug clobazam substantially, and cannabis or CBD can elevate INR and bleeding risk in people stabilized on warfarin. Either warrants closer monitoring.
Sources, station 06
- Devinsky O, et al. CBD in Dravet. NEJM. 2017. PMID 28538134; Lennox-Gastaut. NEJM. 2018. PMID 29768152
- Herman TS, et al. Nabilone vs prochlorperazine. NEJM. 1979. PMID 375088; Jones SE, et al. Cancer Treat Rev. 1982. PMID 6299555
- Whiting PF, et al. Cannabinoids, systematic review. JAMA. 2015. PMID 26103030; Wang L, et al. BMJ. 2021. PMID 34497047
- Beal JE, et al. Dronabinol, HIV wasting. J Pain Symptom Manage. 1995. PMID 7730690
- Safety: Volkow ND, et al. NEJM. 2014. PMID 24897085; Marconi A, et al. psychosis. Schizophr Bull. 2016. PMID 26884547; Compton WM, et al. use disorder. 2019. PMID 31586809; Kamel I, et al. cardiovascular (disputed). JACC Adv. 2025. PMID 40104933; Thompson R, et al. pregnancy. 2019. PMID 31343707
- Interactions: Geffrey AL, et al. clobazam. Epilepsia. 2015. PMID 26114620; warfarin case reports PMID 29387536, 31319733, 30326170, 19531696
STATION 07Preparations
The forms it takes
Described at the level of what each form is, and its medical dosing where a trial established one. Recreational dosing is a separate lane and is not on this page.
Dried flower, smoked or vaporized, gives the fastest onset, cannabinoids in the blood within minutes. Heat does double duty here: it is also the decarboxylation from the still point, turning THCA into THC, which is why the raw plant and the prepared plant are different medicines. Oral forms, the single-cannabinoid capsules dronabinol and nabilone, purified CBD solution, and whole-plant tinctures, come on slower and more variably. Oromucosal spray (nabiximols) absorbs across the cheek. Oils and topicals are in wide use with much thinner evidence on what actually reaches the bloodstream.
Where trials fixed a medical dose: purified CBD for those two epilepsies ran 10 to 20 mg/kg/day; dronabinol for HIV-related appetite loss, 2.5 mg twice daily; nabiximols titrated from one spray toward a typical 6 to 8 per day. For chronic pain the trial literature is too varied to name one regimen.
Sources, station 07
- Spindle TR, et al. Inhaled cannabinoid pharmacokinetics. J Anal Toxicol. 2019. PMID 30615181
- Vandrey R, et al. Oral cannabinoid onset variability. J Anal Toxicol. 2017. PMID 28158482
- Dosing: Devinsky 2017/2018 (PMID 28538134, 29768152); Beal 1995 (PMID 7730690)